Sabadell Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.21M Buy
7,384
+699
+10% +$113K 0.25% 68
2023
Q1
$1.11M Buy
6,685
+746
+13% +$120K 0.24% 77
2022
Q4
$1.04M Hold
5,939
0.22% 91
2022
Q3
$981K Sell
5,939
-293
-5% -$49.6K 0.22% 84
2022
Q2
$1.09M Hold
6,232
0.23% 89
2022
Q1
$1.13M Hold
6,232
0.2% 108
2021
Q4
$1.05M Hold
6,232
0.17% 108
2021
Q3
$1.01M Hold
6,232
0.17% 106
2021
Q2
$1.03M Buy
+6,232
New +$1.03M 0.18% 109

Other funds holding JNJ

Sabadell Asset Management's JNJ Position: Q2 2023 in Review

Sabadell Asset Management increased its Johnson & Johnson (JNJ) stake by 10% in Q2 2023, buying an estimated $113K and bringing the position to 7,384 shares worth $1.21M. The position accounts for 0.25% of the portfolio, ranked #68.

Sabadell Asset Management first reported a position in JNJ in Q2 2021 and has held it in 9 quarters since. 3,752 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • Sabadell Asset Management held 7,384 shares of Johnson & Johnson worth $1.21M as of Q2 2023.
  • Sabadell Asset Management bought 699 Johnson & Johnson shares in Q2 2023, an estimated $113K.
  • Johnson & Johnson made up 0.25% of Sabadell Asset Management's portfolio in Q2 2023, its #68 holding.
  • Sabadell Asset Management first reported a position in Johnson & Johnson in Q2 2021 and has held it in 9 quarters since.
  • 3,752 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Sabadell Asset Management's 13F filing for Q2 2023, filed 23 Jan 2024.